Randomised, double-blind, placebo-controlled, multi-centre trial on the efficacy and safety of budesonide for induction of remission in incomplete microscopic colitis
Phase of Trial: Phase III
Latest Information Update: 19 Jul 2019
Price : $35 *
At a glance
- Drugs Budesonide (Primary)
- Indications Microscopic colitis
- Focus Registrational; Therapeutic Use
- Sponsors Dr Falk Pharma
- 19 Jul 2019 This trial has been completed in Denmark.
- 21 Jun 2019 This trial has been completed in Lithuania.
- 15 Jun 2019 This trial has been completed in Austria.